Dilon Diagnostics, a developer of molecular breast imaging technologies, has become the exclusive U.S. distributor of products from SurgicEye, developer of intraoperative soft tissue imaging and navigation technologies.

Accurate localization of sentinel nodes with SPECT/CT has expanded beyond breast cancer and melanoma to head and neck cancer.